M3-Brigade Acquisition V (NASDAQ:MBAV) Stock Rating Upgraded by Wall Street Zen

Key Points

• Analyst ratings: Wall Street Zen assigned M3-Brigade Acquisition V (MBAV) a "sell" rating and Weiss Ratings reiterated a "sell (d-)", leaving the MarketBeat average rating at Sell.
• Insider purchase: Major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares at $10.80 on Dec. 17 for about $38.1 million, increasing its stake 83% to 7,779,865 shares.
• Stock price vs. trends: MBAV opened at $10.70, with a 50‑day SMA of $10.67 and 200‑day SMA of $10.62, and a 1‑year trading range of $10.19–$13.73.

M3-Brigade Acquisition V (NASDAQ:MBAV - Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a "sell" rating in a research report issued on Saturday.

Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, M3-Brigade Acquisition V currently has an average rating of "Sell".

M3-Brigade Acquisition V Price Performance

Shares of NASDAQ MBAV opened at $10.70 on Friday. The stock has a fifty day simple moving average of $10.67 and a two-hundred day simple moving average of $10.62. M3-Brigade Acquisition V has a 1-year low of $10.19 and a 1-year high of $13.73.

Insider Activity at M3-Brigade Acquisition V

In other M3-Brigade Acquisition V news, major shareholder Fitzgerald & Co. Cantor purchased 3,529,081 shares of the company's stock in a transaction that occurred on Wednesday, December 17th. The shares were bought at an average cost of $10.80 per share, for a total transaction of $38,114,074.80. Following the purchase, the insider owned 7,779,865 shares of the company's stock, valued at $84,022,542. This represents a 83.02% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Institutional Investors Weigh In On M3-Brigade Acquisition V

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC bought a new stake in M3-Brigade Acquisition V during the 2nd quarter valued at $1,978,000. Alberta Investment Management Corp bought a new position in shares of M3-Brigade Acquisition V in the second quarter worth $27,943,000. Magnetar Financial LLC purchased a new position in shares of M3-Brigade Acquisition V in the second quarter valued at $26,254,000. JPMorgan Chase & Co. purchased a new position in shares of M3-Brigade Acquisition V in the second quarter valued at $900,000. Finally, Clear Street LLC raised its stake in shares of M3-Brigade Acquisition V by 2,280.8% during the 2nd quarter. Clear Street LLC now owns 32,069 shares of the company's stock valued at $362,000 after purchasing an additional 30,722 shares during the period.

M3-Brigade Acquisition V Company Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3's digital health platform and real‐world data capabilities, combined with Brigade's deep experience in credit and asset management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.